活性分子抑制剂-Amadis Chemical

图片	名称及描述
	4-(Sulfooxy)benzoicacid 4-(Sulfooxy)benzoicacid A13068373233-38-3 95%	Detail
	(R)-3-羟基十六烷酸 (R)-3-Hydroxyhexadecanoic acid A1307116320595-04-4 98%	Detail
	5-(4-(2-((6-(4-甲氧基苯氧基)嘧啶-4-基)(甲基)氨基)乙氧基)苄基)噻唑烷-2,4-二酮 Lobeglitazone A13071168607723-33-1 98%	Detail
	(5S,6R,7R,9R,16R)-16-羟基-6-甲氧基-5-甲基-7-(甲胺基)-6,7,8,9,15,16-六氢-17-氧杂-4b,9a,15-三氮杂-5,9-甲桥二苯并[b,h]环壬[jkl]环戊基[e]-as-indacen-14(5H)-酮 UCN-01 A13071169112953-11-4 98%	Detail
	MEK Inhibitor II MEK Inhibitor II A13071170623163-52-0 98%	Detail
	N-Methylquipazine N-Methylquipazine A1307117128614-26-8 98%	Detail
	JAK2 Inhibitor IV JAK2 Inhibitor IV A130711721110502-30-1 98%	Detail
	RMC-5127 RMC-5127 A130711743056146-38-1 97%	Detail
	HNF4 agonist 1 HNF4 agonist 1 A13071177 97%	Detail
	JAK3 Inhibitor, Negative Control JAK3 Inhibitor, Negative Control A13071195153437-07-1 98%	Detail
	SGC-AAK1-1N SGC-AAK1-1N A130711962242913-80-8 98%	Detail
	AZ'9567 AZ'9567 A130711973056570-19-2 98%	Detail
	PRL-295 PRL-295 A130711982377770-85-7 98%	Detail
	SGC-CAF268-1N SGC-CAF268-1N A130711992956009-69-9 98%	Detail
	SGC-CAMKK2-1N (UNC-YL-83) SGC-CAMKK2-1N (UNC-YL-83) A130712002561494-74-2 98%	Detail
	SGC-CDKL5GSK3 SGC-CDKL5GSK3 A13071201844442-32-6 98%	Detail
	5-(苄基氨基)嘧啶并[4,5-c]喹啉-8-羧酸 CK2-IN-7 A130712022825012-70-0 98%	Detail
	2-(4-(5-乙酰基-3-(7-(二氟甲基)-6-(1-甲基-1H-吡唑-4-基)-3,4-二氢喹啉-1(2H)-基)-4,5,6,7-四氢-1H-吡唑并[4,3-c]吡啶-1-基)哌啶-1-基)乙酸 2-(4-(5-Acetyl-3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-1-yl)piperidin-1-yl)acetic acid A130712042750072-14-9 98%	Detail
	4,4'-(3-(4-(2-(哌啶-1-基)乙氧基)苯基)-1H-吡唑-1,5-二基)二苯酚 TSI-13-57 A130712092257427-45-3 98%	Detail
	2-(2,6-二氧代哌啶-3-基)-4-(2-(2-羟基乙氧基)乙氧基)乙氧基)-2,3-二氢-1H-异吲哚-1,3-二酮 2-(2,6-Dioxopiperidin-3-yl)-4-(2-(2-(2-hydroxyethoxy)ethoxy)ethoxy)isoindoline-1,3-dione A130712132286368-57-6 95%	Detail